510(k) K163347

xTAG Cystic Fibrosis 39 Kit v2 by Luminex Molecular Diagnostics, Inc. — Product Code NUA

K163347 is an FDA 510(k) premarket notification submitted by Luminex Molecular Diagnostics, Inc. for the device "xTAG Cystic Fibrosis 39 Kit v2". The FDA issued a decision of Substantially Equivalent - Kit on Dec 15, 2016. The device falls under product code NUA (System, Cystic Fibrosis Transmembrane Conductance Regulator, Gene Mutation Detection), a Class II device regulated under 21 CFR 866.5900. Luminex Molecular Diagnostics, Inc. has 25 other 510(k) clearances on record.

Clearance details

Decision
SESK (Substantially Equivalent - Kit)
Decision Date
Dec 15, 2016
Date Received
Nov 28, 2016
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device classification

Device Name
System, Cystic Fibrosis Transmembrane Conductance Regulator, Gene Mutation Detection
Device Class
Class II
Regulation Number
866.5900
Review Panel
PA
Submission Type
510(k)

The cftr gene mutation detection system is a device used to simultaneously detect and identify a panel of mutations and variants in the cftr gene. It is intended as an aid in confirmatory diagnostic testing of individuals with suspected cystic fibrosis (cf), carrier identification, and newborn screening. This device is not intended for stand-alone diagnostic purposes, prenatal diagnostic, pre-implantation or population screening.

Need the full FDA record for Luminex Molecular Diagnostics, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K163347. Report a data issue: hello@regdatalab.com.